Medolife Rx Announces Changes in Management, Puts New Executive Leadership in Place

Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Medolife Rx Announces Changes in Management, Puts New Executive Leadership in Place
QuantRxMay 11, 2021 GMT
Burbank, CA - ( NewMediaWire ) - May 11, 2021 - Medolife Rx, Inc. (“Medolife”), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today its President Philip Sands will be stepping down from the position, completing the planned final step in the merger with Quanta. Stepping into his place, Medolife CEO Dr. Arthur Mikaelian will act as the interim President and Chairman of the Board, while continuing in his role as CEO.

Related Keywords

United States ,Dominican Republic ,America ,Philip Sands ,Tom Nelson ,Arthur Mikaelian ,Kyle Porter ,Exchange Commission ,Medolife Rx Inc ,Aquanta Inc ,President Philip Sands ,Harbor Statement ,Securities Litigation Reform Act ,ஒன்றுபட்டது மாநிலங்களில் ,டொமினிகன் குடியரசு ,அமெரிக்கா ,பிலிப் மணல் ,டோம் நெல்சன் ,கைல் போர்டர் ,பரிமாற்றம் தரகு ,குவாண்டா இன்க் ,துறைமுகம் அறிக்கை ,பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,